Anti-CD20 Radioimmunotherapy Before Chemotherapy and Stem Cell Transplant in Treating Patients With High-Risk B-Cell Malignancies
Conditions: Adult Burkitt Lymphoma; Adult Diffuse Large B-Cell Lymphoma; CD20-Positive Neoplastic Cells Present; Indolent Adult Non-Hodgkin Lymphoma; Mantle Cell Lymphoma; Recurrent B-Cell Non-Hodgkin Lymphoma; Refractory Mature B-Cell Non-Hodgkin LymphomaInterventions: Biological: Anti-CD20 B9E9 scFv-Streptavidin Fusion Protein; Radiation: indium In 111-DOTA-biotin; Radiation: yttrium Y 90 DOTA-biotin; Drug: Clearing Agent; Drug: Carmustine; Drug: Etoposide; Drug: Cytarabine; Drug: Melphalan; Procedure: Peripheral Blood Stem Cell Transplan...
Source: ClinicalTrials.gov - June 23, 2015 Category: Research Source Type: clinical trials